Research is under way to explore whether semaglutide could help boost ovulation in women with obesity and polycystic ovary syndrome (PCOS) a condition which can cause irregular periods, weight gain, and infertility among other symptoms
Important: increasing activity often requires pre-planned insulin reductions
IV therapy is more expensive because it requires clinical staff, sterile compounding and one-on-one care
Research is emerging on the function of GLP-1 in the body, which is good news as many are asking if GLP-1 can help with issues like obesity or even diabetes
Most of the research in this area has focused specifically on alcohol addiction, and researchers have known for a while now from animal studies that GLP-1 receptor agonists decrease alcohol intake, reduce the motivation to consume alcohol, and even prevent relapse drinking by potentially lowering alcohol-induced reward
In parallel, we released a companion report that uses dispense data to examine switching patterns during the same period as the CVS formulary change, providing a complementary perspective on how patients transitioned between GLP-1 RAs
